192 related articles for article (PubMed ID: 23435957)
21. Knockdown of eIF4E suppresses cell proliferation, invasion and enhances cisplatin cytotoxicity in human ovarian cancer cells.
Wan J; Shi F; Xu Z; Zhao M
Int J Oncol; 2015 Dec; 47(6):2217-25. PubMed ID: 26498997
[TBL] [Abstract][Full Text] [Related]
22. Cisplatin-induced apoptosis involves a Fas-ROCK-ezrin-dependent actin remodelling in human colon cancer cells.
Rebillard A; Jouan-Lanhouet S; Jouan E; Legembre P; Pizon M; Sergent O; Gilot D; Tekpli X; Lagadic-Gossmann D; Dimanche-Boitrel MT
Eur J Cancer; 2010 May; 46(8):1445-55. PubMed ID: 20202822
[TBL] [Abstract][Full Text] [Related]
23. Self-targeted knockdown of CD44 improves cisplatin sensitivity of chemoresistant non-small cell lung cancer cells.
Quan YH; Lim JY; Choi BH; Choi Y; Choi YH; Park JH; Kim HK
Cancer Chemother Pharmacol; 2019 Mar; 83(3):399-410. PubMed ID: 30515553
[TBL] [Abstract][Full Text] [Related]
24. Ezrin Phosphorylation at T567 Modulates Cell Migration, Mechanical Properties, and Cytoskeletal Organization.
Zhang X; Flores LR; Keeling MC; Sliogeryte K; Gavara N
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936668
[TBL] [Abstract][Full Text] [Related]
25. The membrane-cytoskeleton organizer ezrin is necessary for hepatocellular carcinoma cell growth and invasiveness.
Zhang Y; Hu MY; Wu WZ; Wang ZJ; Zhou K; Zha XL; Liu KD
J Cancer Res Clin Oncol; 2006 Nov; 132(11):685-97. PubMed ID: 16786358
[TBL] [Abstract][Full Text] [Related]
26. Ezrin expression is altered in mice lymphatic metastatic hepatocellular carcinoma and subcellular fractions upon Annexin 7 modulation in-vitro.
Hago AM; Gamallat Y; Mahmoud SA; Huang Y; Zhang J; Mahmoud YK; Wang J; Wei Y; Wang L; Zhou S; Awsh MA; Yabasin IB; Tang J
Biomed Pharmacother; 2017 Jan; 85():209-217. PubMed ID: 27914826
[TBL] [Abstract][Full Text] [Related]
27. Crosstalk between Raf-MEK-ERK and PI3K-Akt-GSK3β signaling networks promotes chemoresistance, invasion/migration and stemness via expression of CD44 variants (v4 and v6) in oral cancer.
Kashyap T; Pramanik KK; Nath N; Mishra P; Singh AK; Nagini S; Rana A; Mishra R
Oral Oncol; 2018 Nov; 86():234-243. PubMed ID: 30409306
[TBL] [Abstract][Full Text] [Related]
28. Circular RNA hsa_circ_0096157 contributes to cisplatin resistance by proliferation, cell cycle progression, and suppressing apoptosis of non-small-cell lung carcinoma cells.
Lu H; Xie X; Wang K; Chen Q; Cai S; Liu D; Luo J; Kong J
Mol Cell Biochem; 2020 Dec; 475(1-2):63-77. PubMed ID: 32767026
[TBL] [Abstract][Full Text] [Related]
29. Regulation of ezrin tension by S-nitrosylation mediates non-small cell lung cancer invasion and metastasis.
Zhang X; Li G; Guo Y; Song Y; Chen L; Ruan Q; Wang Y; Sun L; Hu Y; Zhou J; Ren B; Guo J
Theranostics; 2019; 9(9):2555-2571. PubMed ID: 31131053
[TBL] [Abstract][Full Text] [Related]
30. RNA interference (RNAi) mediated stable knockdown of protein casein kinase 2-alpha (CK2α) inhibits migration and invasion and enhances cisplatin-induced apoptosis in HEp-2 laryngeal carcinoma cells.
Zhang F; Yang B; Shi S; Jiang X
Acta Histochem; 2014 Jul; 116(6):1000-6. PubMed ID: 24831064
[TBL] [Abstract][Full Text] [Related]
31. RET isoform-specific interaction with scaffold protein Ezrin promotes cell migration and chemotaxis in lung adenocarcinoma.
Moodley S; Lian EY; Crupi MJF; Hyndman BD; Mulligan LM
Lung Cancer; 2020 Apr; 142():123-131. PubMed ID: 32146264
[TBL] [Abstract][Full Text] [Related]
32. Pathophysiological Roles of Actin-Binding Scaffold Protein, Ezrin.
Kawaguchi K; Asano S
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328667
[TBL] [Abstract][Full Text] [Related]
33. Molecular basis of functional exchangeability between ezrin and other actin-membrane associated proteins during cytokinesis.
Yang G; Hiruma S; Kitamura A; Kinjo M; Mishra M; Uehara R
Exp Cell Res; 2021 Jun; 403(2):112600. PubMed ID: 33862101
[TBL] [Abstract][Full Text] [Related]
34. CD44 inhibition attenuates EGFR signaling and enhances cisplatin sensitivity in human EGFR wild‑type non‑small‑cell lung cancer cells.
Yin J; Zhang H; Wu X; Zhang Y; Li J; Shen J; Zhao Y; Xiao Z; Lu L; Huang C; Zhang Z; Du F; Wu Y; Kaboli PJ; Cho CH; Yuan D; Li M
Int J Mol Med; 2020 Jun; 45(6):1783-1792. PubMed ID: 32236608
[TBL] [Abstract][Full Text] [Related]
35. [Expression of ezrin in human non-small cell lung cancer and its relationship with metastasis and prognosis].
Chen QY; Yan J; Hu HZ; Chen FY; Song J; Jiang ZY; Jiao DM; Wu YQ
Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):436-40. PubMed ID: 22967445
[TBL] [Abstract][Full Text] [Related]
36. Lipid raft association restricts CD44-ezrin interaction and promotion of breast cancer cell migration.
Donatello S; Babina IS; Hazelwood LD; Hill AD; Nabi IR; Hopkins AM
Am J Pathol; 2012 Dec; 181(6):2172-87. PubMed ID: 23031255
[TBL] [Abstract][Full Text] [Related]
37. Adducins inhibit lung cancer cell migration through mechanisms involving regulation of cell-matrix adhesion and cadherin-11 expression.
Lechuga S; Amin PH; Wolen AR; Ivanov AI
Biochim Biophys Acta Mol Cell Res; 2019 Mar; 1866(3):395-408. PubMed ID: 30290240
[TBL] [Abstract][Full Text] [Related]
38. Podoplanin (PDPN) affects the invasiveness of thyroid carcinoma cells by inducing ezrin, radixin and moesin (E/R/M) phosphorylation in association with matrix metalloproteinases.
Sikorska J; Gaweł D; Domek H; Rudzińska M; Czarnocka B
BMC Cancer; 2019 Jan; 19(1):85. PubMed ID: 30654768
[TBL] [Abstract][Full Text] [Related]
39. Acetylation of ezrin regulates membrane-cytoskeleton interaction underlying CCL18-elicited cell migration.
Song X; Wang W; Wang H; Yuan X; Yang F; Zhao L; Mullen M; Du S; Zohbi N; Muthusamy S; Cao Y; Jiang J; Xia P; He P; Ding M; Emmett N; Ma M; Wu Q; Green HN; Ding X; Wang D; Wang F; Liu X
J Mol Cell Biol; 2020 Jul; 12(6):424-437. PubMed ID: 31638145
[TBL] [Abstract][Full Text] [Related]
40. [The effects of ezrin on the proliferation and the invasiveness of cells of different hepatocellular carcinoma cell lines].
Zhang Y; Hu MY; Chen BH; Wang ZJ; Wu WZ; Zhou K; Liu KD
Zhonghua Gan Zang Bing Za Zhi; 2006 Jul; 14(7):489-94. PubMed ID: 16867268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
